The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH - van der Klaauw, A A; Biermasz, N R; Feskens, EJ M (European Journal of Endocrinology, 2007)
et al.